Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and ...
An alarm went out early in December from The Lancet, probably the best medical journal in the world. In a special issue ...
CMS has proposed a rule to reinterpret the exclusion of anti-obesity medications from Medicare, Medicaid coverage to allow them to be covered ...
The level of premature death in the U.S. is still unacceptably high. But progress isn’t just about where you are; it’s also ...
Groundbreaking weight-loss drugs like Ozempic and Wegovy have understandably generated a lot of excitement, bringing hope to ...
In a public health breakthrough, U.S. obesity rates have decreased for the first time in more than a decade, with new weight ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
“Despite claims of toxicity, seed oils are largely safe and beneficial in moderation,” says Dr Raysa El Zein, nutrition and ...
The kids seen by Dolores Mejia around suburban Phoenix have been growing heavier in recent years. Their parents, too, she ...
Rachel Smith, Ph.D., is collaborating with researchers across UAB on the two-year project, which will focus on the ...
The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...